KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Acquisitions (2016 - 2025)

Historic Acquisitions for Humana (HUM) over the last 16 years, with Q3 2025 value amounting to $4.0 million.

  • Humana's Acquisitions fell 8000.0% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.0 million, marking a year-over-year increase of 2127.66%. This contributed to the annual value of $89.0 million for FY2024, which is 6180.26% down from last year.
  • According to the latest figures from Q3 2025, Humana's Acquisitions is $4.0 million, which was down 8000.0% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Humana's Acquisitions ranged from a high of $3.6 billion in Q3 2021 and a low of $1.0 million during Q2 2025
  • In the last 5 years, Humana's Acquisitions had a median value of $62.5 million in 2023 and averaged $269.5 million.
  • The largest annual percentage gain for Humana's Acquisitions in the last 5 years was 42000.0% (2024), contrasted with its biggest fall of 9741.38% (2024).
  • Over the past 5 years, Humana's Acquisitions (Quarter) stood at $228.0 million in 2021, then plummeted by 80.7% to $44.0 million in 2022, then tumbled by 77.27% to $10.0 million in 2023, then soared by 420.0% to $52.0 million in 2024, then crashed by 92.31% to $4.0 million in 2025.
  • Its Acquisitions stands at $4.0 million for Q3 2025, versus $1.0 million for Q2 2025 and $52.0 million for Q4 2024.